-720x400.jpg)
Research reveals 16,724 confirmed influenza cases and 273 influenza-associated deaths1 this year, as the country continues to experience a simultaneous COVID-19 and influenza spike this flu season. However, Australians can now self-test for COVID-19 and Influenza A and B at home, following the Therapeutic Goods Administration’s (TGA) approval of a new COVID-19 and Flu A/B Rapid Antigen Combo test.
In response to the critical growing need for an accurate method of diagnosis this flu season, Sydney-based developer and manufacturer, Touch Biotechnology, has released one of the first TGA approved multi-virus diagnostic testing kit in the Australian market (ARTG Number: 395591). TouchBio SARS-CoV-2 & Flu A/B Antigen Combo Test Kit – For Self-Testing has been classified with a clinical sensitivity of ‘very high sensitivity.
A game-changer for Australians and the health industry, the combination test delivers people accurate results within 15 minutes. By allowing Aussies to diagnose their symptoms faster and without the need for testing within the community, this will reduce the risk of spreading significant illnesses and ease the burden on our already overloaded hospital systems.
Similar to the COVID RAT test Aussies have grown used to, the combination test requires a single nasal swab specimen which enables the qualitative detection of COVID-19 and Influenzas A and B viruses. Easy to use at home and workplaces, this test requires no specialised training for the collection and testing of samples.
Australians are recommended to take a COVID-19 and Flu A/B Rapid Antigen Combo Test when they feel unwell, have any symptoms or have been in contact with someone who has these viruses. The COVID-19 and Flu A/B Rapid Antigen Combo Test (Self-Testing) will be available to purchase online at www.touchaustralia.com.au.
Founded in 2020 in Sydney Australia, Touch Biotechnology is one of the leading manufacturer and developer of advanced antimicrobial protection solutions and rapid in-vitro antigen tests. It is dedicated to developing solutions that are evidently effective, and continually demonstrates a commitment to building products that have a positive impact on human lives, while remaining socially and environmentally responsible.
